Evidence of superiority of sacubitril/valsartan versus angiotensin-converting enzyme inhibitors or angiotensin ii receptor blockers in the heart failure with reduced …
Abstract Sacubitril/valsartan (S/V) is a new drug which has been recently recommended by
the international guidelines for the treatment of patients with chronic heart failure (HF) with …
the international guidelines for the treatment of patients with chronic heart failure (HF) with …
Evidence of superiority of sacubitril/valsartan versus angiotensin-converting enzyme inhibitors or angiotensin ii receptor blockers in the heart failure with reduced …
M Gori, E D'Elia, M Senni - Cardiology Plus, 2021 - go.gale.com
Sacubitril/valsartan (S/V) is a new drug which has been recently recommended by the
international guidelines for the treatment of patients with chronic heart failure (HF) with …
international guidelines for the treatment of patients with chronic heart failure (HF) with …